Мальта - англійська - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - salmeterol, fluticasone propionate - pressurised inhalation, suspension - salmeterol 25 µg fluticasone propionate 125 µg - drugs for obstructive airway diseases

Мальта - англійська - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - salmeterol, fluticasone propionate - pressurised inhalation, suspension - salmeterol 25 µg fluticasone propionate 250 µg - drugs for obstructive airway diseases

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

fannin limited - fluticasone propionate; salmeterol xinafoate - pressurised inhalation, suspension - 25 / 125 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

fannin limited - fluticasone propionate; salmeterol xinafoate - pressurised inhalation, suspension - 25/250 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

pharmaram ltd - fluticasone propionate; salmeterol xinafoate - pressurised inhalation - 125microgram/1dose ; 25microgram/1dose

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

pharmaram ltd - fluticasone propionate; salmeterol xinafoate - pressurised inhalation - 250microgram/1dose ; 25microgram/1dose

ПАР - англійська - South African Health Products Regulatory Authority (SAHPRA)

glaxosmithkline south africa (pty) limited - inhaler - see ingredients - each metered dose delivers salmeterol 25,0 ug